Shoulder Prosthesis Telerehab Care Trial (PROTECT)

April 11, 2024 updated by: University Hospital, Ghent

The PROTECT-study: Home-based Telerehabilitation in the Post-operative Care After Shoulder Arthroplasty Compared to Usual Care: a Randomized Control Trial

The goal of this clinical trial is to compare the rehabilitation by use of a smartphone-app with the usual care of physical therapy in patients, 60 years and older, who underwent a primary shoulder arthroplasty.

The main questions it aims to answer are:

  • is the outcome of rehabilitation with the app as good as the usual care?
  • is the outcome for both types of shoulder arthroplasty similar?
  • what is the usability of the app?.

Participants will

  • have treatment according to the group they are allocated to
  • fill in questionnaires at specific moments during the rehabilitation stage (0 - 3 months ) and at 1 year post-surgery

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 60 years and older
  • primary total shoulder arthroplasty (anatomical and reverse)
  • osteoarthritis, cuff tear arthropathy, pseudoparalysis
  • return home after discharge from hospital
  • no brace after surgery
  • sufficient verbal and written comprehension
  • hospitalization insurance

Exclusion Criteria:

  • revision arthroplasty
  • arthroplasty for fracture or tumor
  • neurological disease (parkinson, stroke, ...)
  • no access to smartphone, tablet or internet connectivity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: APP-GROUP
Patients allocated in the app-group will use the app to rehabilitate.
Patients allocated in the app-group will use the newly developed smartphone app te rehabilitate. 5 exercises are provided daily. Daily questionnaires will monitor exercise performance, VAS pain, household activities. Information modules will be sent at specific times.
Active Comparator: PHYSIO-GROUP
Patients allocated in the physio-group will rehabilitate according to the usual care protocol
Patients allocated in the physio-group will go, twice a week, to a physical therapist of their choice to rehabilitate. The physical therapist will follow the general guidelines provided by the hospital (surgeon).
Other Names:
  • PHYSIO-GROUP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SHOULDER PAIN AND DISABILITY INDEX (SPADI)_baseline pre-operative
Time Frame: Prior to surgery

Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

Prior to surgery
SHOULDER PAIN AND DISABILITY INDEX (SPADI)_baseline post-operative
Time Frame: week 0

Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

week 0
SHOULDER PAIN AND DISABILITY INDEX (SPADI)
Time Frame: week 3

Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

week 3
SHOULDER PAIN AND DISABILITY INDEX (SPADI)
Time Frame: week 6

Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

week 6
SHOULDER PAIN AND DISABILITY INDEX (SPADI)
Time Frame: week 12

Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

week 12
SHOULDER PAIN AND DISABILITY INDEX (SPADI)
Time Frame: week 52

Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

week 52

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ACTIVE MOBILITY (ROM) OF THE SHOULDER
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

ACTIVE ROM: forward flexion and abduction with extended elbow, functional internal and external rotation in standing position.

  • maximal pain free ROM
  • forward flexion and abduction with extended elbow: measured with the EasyAngle (Meloq AB Sweden)
  • hand-to-back and hand-nek test : scored as in Constant-Murley Score

    2) PASSIVE: forward flexion, abduction, external and internal rotation in supine position.

  • maximal pain free ROM
  • forward flexion and abduction: measured with the EasyAngle (Meloq AB Sweden)
  • rotations: measured as ER1 (arm at the side)/ ER2 (arm in 90° abduction) and IR1 (arm in 90° forward flexion)/ IR2 (arm in 90° abduction) with the EasyAngle (Meloq AB Sweden).
Prior to surgery, week 3, week 6, week 12, week 52
PASSIVE MOBILITY (ROM) OF THE SHOULDER
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

PASSIVE: forward flexion, abduction, external and internal rotation in supine position.

  • maximal pain free ROM
  • forward flexion and abduction: measured with the EasyAngle (Meloq AB Sweden)
  • rotations: measured as ER1 (arm at the side)/ ER2 (arm in 90° abduction) and IR1 (arm in 90° forward flexion)/ IR2 (arm in 90° abduction) with the EasyAngle (Meloq AB Sweden).
Prior to surgery, week 3, week 6, week 12, week 52
STRENGTH
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

Forward flexion, extension, ab- and adduction, external and internal rotation.

  • isometrical contraction for 5 seconds, 3 repetitions, 30 sec break in between
  • measured with EasyForce (Meloq AB Sweden)
  • seated, both feet on the ground, back against backrest
  • elbow flexed (90°) held at side, fist forward, thumb upward
Prior to surgery, week 3, week 6, week 12, week 52
CONSTANT-MURLEY SCORE
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

Content: partially clinical (65 points) and partially PROM (35 points) assessed.

Scoring: The formula to calculate the total score is:" pain (0-15) + ADL (4x (0-5) = 0-20) + mobility (4 x (0-10) = 0-40) + strength (0 -25)". Strength will be measured with the arm elevated to 90 ° in the scapular plane using an IDOmeter.

Interpretation: 0-55 points = bad, 56-70 points = mediocre, 71-85 points = good, 86-100 points = excellent score

Prior to surgery, week 3, week 6, week 12, week 52
ACTIVITIES OF DAILY LIVING EXTERNAL AND INTERNAL ROTATIONS (ADLEIR)
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

Content: 12 questions about specific ADL tasks that require external or internal rotation while performing.

Scoring: Each activity is scored between 0 (unable to do) and 3 (not difficult at all). All activities should be performed without the help of flexing the neck or bending the trunk and without the help of first abducting the elbow (i.e., without doing a hornblower sign).

Interpretation: The maximal score is 36. A higher score means that the patient is able to perform ADL activities with enough strength in external and internal rotation

Prior to surgery, week 3, week 6, week 12, week 52
SINGLE ASSESSMENT NUMERIC EVALUATION (SANE)
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

Content: 1 question: 'how would you rate your shoulder today as a percentage of normal?'.

Scoring: percentage between 0 and 100% Interpretation: 100% being a normal shoulder.

Prior to surgery, week 3, week 6, week 12, week 52
EUROQOL 5-DIMENSIONS 5-LEVEL (EQ-5D-5L)
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

Content: 5 questions + EQ-5D VAS for general health. Scoring: 5-response scale (from 'no problems' to 'extreme problems') + VAS percentage between 0 (worst imaginable health state) and 100 (best imaginable health state).

Interpretation: VAS score for general health indicates how a patient perceives his general health, Other questions are descriptive for problems in mobility, self-care, usual activities, pain/ discomfort, anxiety/depression.

Prior to surgery, week 3, week 6, week 12, week 52
GRONINGEN ACTIVITY RESTRICTION SCALE (GARS-4)
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

Content: 18 questions to identify problems with self-sufficiency in self-care and housekeeping. Patients do not respond if they do that activity but rather if they could do that activity.

Scoring: ordinal scale from 1 (Yes, I can do that on my own without any effort) up to 4 (No, I can't do that on my own, but only with the help of others).

Interpretation: A higher score (max 72) is related to a lower self-sufficiency.

Prior to surgery, week 3, week 6, week 12, week 52
EXERCISE ADHERENCE RATING SCALE (EARS)
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

Content: 3 sections section A: 6 questions to evaluate the prescribed exercises. section B: 6 questions on how a patient does the recommended exercises or activities.

section C: 10 statements on why a patient does or does not do the recommended exercises or activities.

Scoring: sections B and C: 5-point Likert scale (0 - 4) (some questions scored reversed).

Interpretation:

section B (range 0 - 24): a higher score indicates a better compliance/adherence .

section C (range 0 - 40): a higher score indicates a better adherence.

Prior to surgery, week 3, week 6, week 12, week 52
EXERCISE DIARY
Time Frame: Daily post-surgery (week 0 - week 12)
Content: performed exercises, household activities, VAS pain. Diary on paper for physio-group, by the app for the app-group.
Daily post-surgery (week 0 - week 12)
SELF-EFFICACY FOR EXERCISES (SEE)
Time Frame: Week 3, week 6, week 12, week 52

Content: 9 questions about 'confidence in engaging in exercise 3 times a week for 20 minutes if faced with a barrier'.

Scoring: 'not very confident' (0) and 'very confident' (10). Interpretation: The higher the score , the patient feel more confident in performing prescribed exercises.

Week 3, week 6, week 12, week 52
GLOBAL RATING OF CHANGE SCALE (GROC)
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

Content: A single question (How would you currently describe the change in your operated shoulder compared to just before surgery) is scored on a scale, ranging from 'very much worse' through 'unchanged' to 'completely recovered'.

Scoring: The scale used is divided in 11 points ( very much worse -5, the same 0, very much better + 5) Interpretation: the number given indicates how a patient perceives the change after surgery.

Prior to surgery, week 3, week 6, week 12, week 52
GLOBAL PERCEIVED EFFECT (GPE/GEE)
Time Frame: Prior to surgery, week 3, week 6, week 12, week 52

Content: 2 questions: To what extent have you recovered from your symptoms?, How satisfied are you with your treatment?.

Scoring: a 7-point rating scale. Interpretation: The higher the score , the better.

Prior to surgery, week 3, week 6, week 12, week 52

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
M-HEALTH APP USABILITY QUESTIONNAIRE (MAUQ)
Time Frame: Week 12

Content: 21 questions in 3 categories: ease of use and satisfaction, system information arrangement, usefulness (version for interactive app, user patient and provider).

Scoring: between 1 (strongly disagree) and 7 (strongly agree) => average score. Interpretation: the higher the score the higher the usability.

Week 12
SYSTEM USABILITY SCALE (SUS)
Time Frame: Week 12

Content: 10 questions about system satisfaction, usability and learnability. Scoring: 5 response options ranging from strongly disagree (1) to strongly agree (5).

Interpretation: A score above 68 (/100) is considered above average, while a score lower than 68 is considered a below average score.

Week 12
SINGLE EASE QUESTION (SEQ)
Time Frame: Week 12

Content: 1 question to assess how difficult users find a task. Scoring: 7-point rating scale ranging from very difficult (1) to very easy (7).

Interpretation: The average SEQ score is 5.5 (between 5.3 and 5.6). It is advised to ask a more detailed information/ explanation if a score <5 is given.

Week 12
AGE
Time Frame: Pre-surgery
Content: specify age of participant
Pre-surgery
GENDER
Time Frame: Pre-surgery
Content: specify gender of participant
Pre-surgery
DIAGNOSTICS
Time Frame: Pre-surgery
Content: specify why patient needed a shoulder arthroplasty
Pre-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Alexander Van Tongel, PhD, University Ghent, University Hospital Ghent
  • Study Chair: Ann Cools, PhD, University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

December 23, 2022

First Submitted That Met QC Criteria

January 16, 2023

First Posted (Actual)

January 26, 2023

Study Record Updates

Last Update Posted (Actual)

April 12, 2024

Last Update Submitted That Met QC Criteria

April 11, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ONZ-2022-0357

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on SHOULDER ARTHROPLASTY

Clinical Trials on APP

Subscribe